SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-005099
Filing Date
2021-02-10
Accepted
2021-02-09 19:42:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A apvo-defa14a_20210209.htm DEFA14A 38663
  Complete submission text file 0001564590-21-005099.txt   39639
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37746 | Film No.: 21608605
SIC: 2834 Pharmaceutical Preparations